MoneyWorks4Me

Neuland Laboratories - Quaterly Results

10 May 2022 Evaluate
The Total revenue for the quarter ended March 2022 of  Rs. 2558.73 millions remain, more or less, the same.The company has announced a 26.69% increase in its profits to Rs . 218.27  millions for the  quarter ended March 2022 compared to Rs. 172.28 millions in the corresponding quarter in the previous year.A decline of 393.44 millions was observed in the OP in the quarter ended March 2022 from 400.35 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 2558.73 2447.05 4.56 9510.77 9369.13 1.51 9510.77 9369.13 1.51
Other Income 6.31 145.96 -95.68 20.77 160.95 -87.10 20.77 160.95 -87.10
PBIDT 393.44 400.35 -1.73 1442.70 1625.38 -11.24 1442.70 1625.38 -11.24
Interest 27.70 45.78 -39.49 134.94 178.98 -24.61 134.94 178.98 -24.61
PBDT 365.74 354.57 3.15 1307.76 1446.40 -9.59 1307.76 1446.40 -9.59
Depreciation 124.52 111.41 11.77 490.36 396.78 23.58 490.36 396.78 23.58
PBT 241.22 243.16 -0.80 817.40 1049.62 -22.12 817.40 1049.62 -22.12
TAX 22.95 70.88 -67.62 182.06 246.67 -26.19 182.06 246.67 -26.19
Deferred Tax -47.35 23.87 -298.37 -22.16 121.84 -118.19 -22.16 121.84 -118.19
PAT 218.27 172.28 26.69 635.34 802.95 -20.87 635.34 802.95 -20.87
Equity 129.00 129.00 0.00 129.00 129.00 0.00 129.00 129.00 0.00
PBIDTM(%) 15.38 16.36 -6.02 15.17 17.35 -12.56 15.17 17.35 -12.56
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..